What New Research Suggests About GLP-1 Drugs in Adolescents

A new CBS News report highlights growing interest in GLP-1 medications for adolescents with obesity. Here’s what the latest evidence says, what is still unknown, and why doctors are being cautious.
GLP-1 Weight-Loss Drugs: Rare Harms, Real Tradeoffs

New reporting and medical evidence are sharpening the picture of GLP-1 drug safety: serious complications appear uncommon, but some risks are real and worth discussing before and during treatment.
FDA Adds Rare Eye-Risk Warning to GLP-1 Medicines

The FDA is requiring warning-label updates for GLP-1 drugs after reviewing data on a rare eye condition that can cause sudden, permanent vision loss.
GLP-1 Use Is Tilting Toward Weight Loss, and That Matters

New research highlighted by CBS News suggests GLP-1 medicines are increasingly being used for weight management, with implications for diabetes care, access, and expectations around these popular drugs.